Phenomenex at HPLC 2026

Chromatography Innovation, Delivered.

LUNCH SEMINAR: Assay to Aggregates: Chromatographic Workflows for Therapeutic Peptides and Their Unique Impurities

• Monday, June 8
• 12:30 AM - 1:30 PM
• JW Marriott Indianapolis
• Sean Orlowicz (Principal Market Developmenz Manager – Pharma Phenomenex)

Therapeutic peptides are a rapidly growing drug class that present unique analytical and chromatographic challenges, requiring advanced strategies to accurately separate and characterize closely related impurities, degradation products, and higher‑order species.

Reserve your lunch and seat

POSTER SESSIONS

• 10:00 AM - 11:00 AM
• 3:00 PM - 4:30 PM
• JUNE 8 - 11
• Griffin Hall

Meet our scientific experts and learn about the latest advances in separation science with insights you can apply directly to your lab.

Monday, June 8

Impact of Column Hardware Systems on (U)HPLC Column Performance (ID 61)

• Jason Anspach, Ph.D., Director – Research and Open Innovation, Phenomenex

Retention and Efficiency Improvements in HILIC with a Modified Silica Diol Phase (ID 214)

• Maryam Sayeed, MS, Product Manager, Phenomenex

Improved Column Lifetime in Biological Matrices Using Novel Hardware Technology for LC-MS/MS Analysis (ID 241)

• Grace Guo, MSE, Technical Specialist, Phenomenex

Aggregate Analysis of Common GLP-1s (ID 247)

• Sean Orlowicz, Principal Market Development Manager - Pharmaceutical, Phenomenex

Modernization of USP Methods Using Core-Shell Columns: Improved Efficiency and Throughput for Nifedipine and Flurbiprofen (ID 242)

• Grace Guo, MSE, Technical Specialist, Phenomenex

Integrated Assay and Stability Indicating HPLC Methods for Semaglutide Using a Core Shell Peptide Column (ID 244)

• Sean Orlowicz, Principal Market Development Manager - Pharmaceutical, Phenomenex

Development of an LC-MS/MS Method for Quantitation of Insulin Degludec in Rat Plasma (ID 274)

• Chris Leitner, Senior Territory Manager, SCIEX

Future-Proof LC-MS/MS Solution for Analysis of Nitrosamines in Esomeprazole API (ID 275)

• Anna Smallwood, Product Manager, SCIEX

Quantitation of N-Nitroso Sitagliptin Impurity (NTTP) in Sitagliptin API – Targeted and Untargeted Analysis Track (ID 276)

• Tilak Chandrasekaran, Market Development Manager, Pharmaceutical, SCIEX

Tuesday, June 9

Chemo- and Enantioselectivity with Polysaccharide-Based Chiral Selectors: A Unique Solution to Challenging Separations for Closely Related (Chiral) Compounds (ID 156)

• Tividar Farkas, Senior Managing Scientist, Phenomenex

Separation and Identification of Individual Intact Antibody–Drug Conjugates by Native Reverse Phase LC–MS (ID 219)

• Miklos Czaun, PhD, Senior R&D Manager, Phenomenex

A LC-MS Ready Size Exclusion Chromatographic Platform Method for Oligonucleotide and mRNA Identification (ID 182)

• Crystal Holt, MS, Senior Director, Global Marketing & GC Business Unit Manager, Phenomenex

Characterization of N-Glycan Species of VEGF Decoy Receptor Fusion Protein by BioZen Glycan HILIC Separation with High Sensitive Mass Spectrometric Analysis (ID 300)

• Feng Qin, Senior Product Manager, SCIEX

Wednesday, June 10

Systematic LC Method Development: A Case Study on Mupirocin (ID 195)

• Jenny Lewis, Global Marketing, Phenomenex

Improved Sensitivity and Selectivity for Ultra-Short-Chain PFAS in Tomatoes Using LC-MS/MS Analysis (ID 197)

• Maryam Sayeed, MS, Product Manager, Phenomenex